Literature DB >> 18820122

Bronchial asthma on Mount Kilimanjaro is not a disadvantage.

S Stokes, N Kalson, M Earl, H Frost, A G Whitehead, I Tyrrell-Marsh, A Davies.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18820122     DOI： 10.1136/thx.2008.102327

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

1.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

Review 2.  Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment.

Authors:  Kirsten Holthof; Pierre-Olivier Bridevaux; Isabelle Frésard
Journal:  BMC Pulm Med       Date:  2022-05-09       Impact factor: 3.320

3.  Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment.

Authors:  Pontus Mertsch; Jeremias Götschke; Julia Walter; Carlo Mümmler; Alessandro Ghiani; Ulrike Schürmann; Rosemarie Kiefl; Rudolf Maria Huber; Jürgen Behr; Nikolaus Kneidinger; Katrin Milger
Journal:  World Allergy Organ J       Date:  2022-09-24       Impact factor: 5.516
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.